Gene Therapy for Alopecia in Type II Rickets Model Rats Using Vitamin D Receptor-Expressing Adenovirus Vector

    Satoko Kise, Ayano Iijima, Chika Nagao, Tadashi Okada, Miyu Nishikawa, Shinichi Ikushiro, Teruyuki Nakanishi, Shigeto Sato, Kaori Yasuda, Toshiyuki Sakaki
    Image
    Studysummary In this study, gene therapy using a VDR-expressing adenoviral vector significantly improved hair growth and reduced cyst formation in Vdr -KO rats with alopecia linked to type II rickets, whereas control treatments did not show these effects.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the use of gene therapy to treat alopecia in rats with type II rickets, a hereditary disease caused by a mutation in the vitamin D receptor (VDR) gene. Six 7-week-old female rats with a VDR gene knockout (Vdr-KO) were treated with an adenoviral vector (AdV) expressing the VDR gene. The treated rats showed significant VDR expression in the skin, enhanced hair growth, and low cyst formation, unlike the control groups. This suggests that gene therapy using a VDR-expressing AdV could be a potential treatment for alopecia associated with type II rickets.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results